Skip to content

Effect of opioids on heart under general anaesthesia

Comparison of the effects of Remifentanil and Alfentanil on QT interval in elective surgery under general anaesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201210172310N2
Enrollment
60
Registered
2014-01-20
Start date
2008-06-03
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: conduction disorder. Condition 2: General anesthesia. Other specified conduction disorders Cardiac arrest, unspecified

Interventions

Intervention 1: In one group , as anesthetic premedication , bolus dose of intravenous remifentanil (2 µg / kg over 60 seconds) will be given followed by its infusion ( 0.15 µg / kg / min ) throught
Prevention
In one group , as anesthetic premedication , bolus dose of intravenous remifentanil (2 µg / kg over 60 seconds) will be given followed by its infusion ( 0.15 µg / kg / min ) throught maintenance of
In the other group , as anesthetic premedication , bolus dose of alfentanil ( 20 µg / kg over 60 seconds ) will be followed by its infusion ( 0.25 µg / kg / min )throught maintenance of anesthesia

Sponsors

Shiraz university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age between 18-35 years; ASA - PS ( American Society of Anesthesiologist- Physical Status) : I ; Elective ENT ( Ear-Nose-Throat ) operation under general anesthesia. Exclusion criteria : Abnormal serum electrolytes, cardiovascular or psychiatric problems; idiopathic or acquired prolonged QT interval;anticipated difficulty in tracheal intubation ; patients taking any medication affecting QTc interval ( e.g. :tricylic antidepressant ,antidysrhythmics, ß-adrenergic antagonists, calcium channel blockers); existence of cardiac valvular disease; any cardiac rhythm abnormality; diabetes mellitus ; pregnancy ; obesity ( body mass index > 30 ) and hypersensitivity reaction to egg, fish or soya bean .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
QT interval. Timepoint: Before and 90 seconds after induction of anesthesia, 1 and 5 minutes after endotracheal intubation. Method of measurement: Electrocardiograph.

Secondary

MeasureTime frame
Heart rate. Timepoint: Before and 90 seconds after induction of anesthesia, 1 and 5 minutes after endotracheal intubation. Method of measurement: Operating room monitor.;Blood pressure. Timepoint: Before and 90 seconds after induction of anesthesia, 1 and 5 minutes after endotracheal intubation. Method of measurement: Operating room monitor.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMansoor Masjedi,

Shiraz Anesthesiology and Critical Care Research Center, Department Of Anesthesia, Medical school ,

masjedi@sums.ac.ir , mansoormasjedi@yahoo.com+98 71 1647 4270

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026